Neuroleptic malignant syndrome should be considered as a differential diagnosis in patients on psychotropic medications who present with ileus and delayed fever.
Answers are grounded in this paper and cite their sources.
Atypical NMS with delayed fever and ileus warrants clinical vigilance; extends recognized presentations but leaves diagnostic criteria open.
The pathophysiology of neuroleptic malignant syndrome (NMS) with use of psychotropic drugs is still unclear. Although a rare event with an incidence of 0.02-3.2%, when not promptly recognized and managed, it carries a high mortality (10-20%) and morbidity rate. Presentation can be either typical, with muscle rigidity and hyperpyrexia, or atypical, the latter posing diagnostic and early management challenges in clinical practice. Our patient presented with delayed fever and ileus, making early diagnosis difficult. We propose that NMS be considered an alternate diagnosis in patients using psychotropic medications and manifest ileus and delayed fever, especially after other differentials have been excluded.
No takes yet. Share an insight, caveat, or question.
Chime et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: